Seeyond Gilead Sciences, Inc. Transaction History

Seeyond

$1.03 Billion
Q4 2022

A detailed history of Seeyond transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Seeyond holds 126,063 shares of GILD stock, worth $8.65 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares

126,063

Previous 162,921 22.62%

Holding current value

$8.65 Million

Previous $10.1 Million 7.68%

% of portfolio

1.05%

Previous 1.21%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $2.3 Million - $3.3 Million	-36,858 Reduced 22.62%	126,063 $10.8 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $2.17 Million - $2.48 Million	36,459 Added 28.83%	162,921 $10.1 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $153,015 - $172,341	2,651 Added 2.14%	126,462 $7.82 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $1.21 Million - $1.52 Million	20,878 Added 20.28%	123,811 $7.36 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $238,239 - $270,406	3,672 Added 3.7%	102,933 $7.47 Million

Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $2.3 Million - $2.48 Million	-34,010 Reduced 25.52%	99,261 $6.93 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $1.61 Million - $1.76 Million	25,441 Added 23.59%	133,271 $9.18 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $309,780 - $353,458	5,163 Added 5.03%	107,830 $6.97 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $551,714 - $628,652	-9,739 Reduced 8.66%	102,667 $5.98 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $4.57 Million - $5.74 Million	73,549 Added 189.28%	112,406 $7.1 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $2.73 Million - $3.17 Million	-37,698 Reduced 49.24%	38,857 $2.99 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $2.71 Million - $3.47 Million	43,247 Added 129.84%	76,555 $508,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $76,593 - $84,250	-1,243 Reduced 3.6%	33,308 $2.16 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $94,515 - $104,328	1,512 Added 4.58%	34,551 $2.19 Million
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $400,979 - $449,651	-6,481 Reduced 16.4%	33,039 $2.23 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $1.13 Million - $1.26 Million	18,015 Added 83.77%	39,520 $2.57 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $1.3 Million - $1.7 Million	21,505 New	21,505 $1.35 Million

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seeyond, based on Form 13F filings with the SEC.

News

Stay updated on Seeyond with notifications on news.

Account